merck glp-1 Partners with Hansoh Pharma on Oral Receptor Agonist for Type 2 Diabetes The GLP-1 Revolution: From Diabetes

The dual agonism of GLP-1 and GIP receptor was achieved by replacing the tryptophan cage of exendin-4 with the C-terminal undecapeptide sequence of oxyntomodulin along with a single amino acid substitution from histidine to tyrosine at the amino terminus of the peptide

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: an in-depth review

Wharton S, Lingvay I, Bogdanski P, et al

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion

He demonstrated GIPs ability to lower blood glucose by promoting insulin release from the pancreas in animals and humans

120 IRF4 also regulates macrophage M2 polarization by increasing IL-10 expression, promotes colonic mucosal epithelial cell proliferation, inhibits inflammation, and promotes tissue repair